Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features

Shyr Yi Lin, Kun Tu Yeh, Willian Tzu Liang Chen, Hung Chang Chen, Shou Tung Chen, Hung Yi Chiou, Jan Gowth Chang

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Aberrant promoter methylation of CpG islands of tumor suppressor genes inhibits expression of the genes and may lead to tumorigenesis. We investigated the aberrant methylation profile of potential tumor suppressor genes of p15, p16, SOCS-1, and Wnt signaling pathway in colorectal cancers and correlated the data with clinical findings. Cancerous and nearby non-cancerous tissues of 185 sporadic colorectal cancer samples were studied. Methylation specific PCR was performed to explore the mechanism of inactivation in p15, p16, SOCS-1, E-cadherin, APC, GSK-3β, and Axin1 genes. Aberrant promoter methylation in p15, p16, SOCS-1, E-cadherin, APC, GSK-3β, and Axin1 genes were 5.9, 7.0, 3.8, 5.9, 12.4, 2.2, and 0% for cancerous tissues, respectively, whereas the frequencies were 3.8, 0, 0, 7.0, 2.7, 0.5, and 0% for nearby non-cancerous tissues, respectively. The frequency of aberrant promoter methylation of cancerous tissues was significant higher than non-cancerous tissues in p16, SOCS-1, and APC genes (p

Original languageEnglish
Pages (from-to)341-348
Number of pages8
JournalOncology Reports
Volume11
Issue number2
Publication statusPublished - Feb 2004

Fingerprint

Tumor Suppressor Genes
Methylation
Colorectal Neoplasms
Glycogen Synthase Kinase 3
Cadherins
APC Genes
Genes
CpG Islands
Wnt Signaling Pathway
Carcinogenesis
Gene Expression
Polymerase Chain Reaction

Keywords

  • Direct sequencing
  • Immunohistochemistry
  • Methylation specific PCR
  • Multiple methylation phenotype
  • Tumor suppressor genes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features. / Lin, Shyr Yi; Yeh, Kun Tu; Chen, Willian Tzu Liang; Chen, Hung Chang; Chen, Shou Tung; Chiou, Hung Yi; Chang, Jan Gowth.

In: Oncology Reports, Vol. 11, No. 2, 02.2004, p. 341-348.

Research output: Contribution to journalArticle

Lin, Shyr Yi ; Yeh, Kun Tu ; Chen, Willian Tzu Liang ; Chen, Hung Chang ; Chen, Shou Tung ; Chiou, Hung Yi ; Chang, Jan Gowth. / Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features. In: Oncology Reports. 2004 ; Vol. 11, No. 2. pp. 341-348.
@article{41de9111447640919f21c2f1504c99a0,
title = "Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features",
abstract = "Aberrant promoter methylation of CpG islands of tumor suppressor genes inhibits expression of the genes and may lead to tumorigenesis. We investigated the aberrant methylation profile of potential tumor suppressor genes of p15, p16, SOCS-1, and Wnt signaling pathway in colorectal cancers and correlated the data with clinical findings. Cancerous and nearby non-cancerous tissues of 185 sporadic colorectal cancer samples were studied. Methylation specific PCR was performed to explore the mechanism of inactivation in p15, p16, SOCS-1, E-cadherin, APC, GSK-3β, and Axin1 genes. Aberrant promoter methylation in p15, p16, SOCS-1, E-cadherin, APC, GSK-3β, and Axin1 genes were 5.9, 7.0, 3.8, 5.9, 12.4, 2.2, and 0{\%} for cancerous tissues, respectively, whereas the frequencies were 3.8, 0, 0, 7.0, 2.7, 0.5, and 0{\%} for nearby non-cancerous tissues, respectively. The frequency of aberrant promoter methylation of cancerous tissues was significant higher than non-cancerous tissues in p16, SOCS-1, and APC genes (p",
keywords = "Direct sequencing, Immunohistochemistry, Methylation specific PCR, Multiple methylation phenotype, Tumor suppressor genes",
author = "Lin, {Shyr Yi} and Yeh, {Kun Tu} and Chen, {Willian Tzu Liang} and Chen, {Hung Chang} and Chen, {Shou Tung} and Chiou, {Hung Yi} and Chang, {Jan Gowth}",
year = "2004",
month = "2",
language = "English",
volume = "11",
pages = "341--348",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "2",

}

TY - JOUR

T1 - Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features

AU - Lin, Shyr Yi

AU - Yeh, Kun Tu

AU - Chen, Willian Tzu Liang

AU - Chen, Hung Chang

AU - Chen, Shou Tung

AU - Chiou, Hung Yi

AU - Chang, Jan Gowth

PY - 2004/2

Y1 - 2004/2

N2 - Aberrant promoter methylation of CpG islands of tumor suppressor genes inhibits expression of the genes and may lead to tumorigenesis. We investigated the aberrant methylation profile of potential tumor suppressor genes of p15, p16, SOCS-1, and Wnt signaling pathway in colorectal cancers and correlated the data with clinical findings. Cancerous and nearby non-cancerous tissues of 185 sporadic colorectal cancer samples were studied. Methylation specific PCR was performed to explore the mechanism of inactivation in p15, p16, SOCS-1, E-cadherin, APC, GSK-3β, and Axin1 genes. Aberrant promoter methylation in p15, p16, SOCS-1, E-cadherin, APC, GSK-3β, and Axin1 genes were 5.9, 7.0, 3.8, 5.9, 12.4, 2.2, and 0% for cancerous tissues, respectively, whereas the frequencies were 3.8, 0, 0, 7.0, 2.7, 0.5, and 0% for nearby non-cancerous tissues, respectively. The frequency of aberrant promoter methylation of cancerous tissues was significant higher than non-cancerous tissues in p16, SOCS-1, and APC genes (p

AB - Aberrant promoter methylation of CpG islands of tumor suppressor genes inhibits expression of the genes and may lead to tumorigenesis. We investigated the aberrant methylation profile of potential tumor suppressor genes of p15, p16, SOCS-1, and Wnt signaling pathway in colorectal cancers and correlated the data with clinical findings. Cancerous and nearby non-cancerous tissues of 185 sporadic colorectal cancer samples were studied. Methylation specific PCR was performed to explore the mechanism of inactivation in p15, p16, SOCS-1, E-cadherin, APC, GSK-3β, and Axin1 genes. Aberrant promoter methylation in p15, p16, SOCS-1, E-cadherin, APC, GSK-3β, and Axin1 genes were 5.9, 7.0, 3.8, 5.9, 12.4, 2.2, and 0% for cancerous tissues, respectively, whereas the frequencies were 3.8, 0, 0, 7.0, 2.7, 0.5, and 0% for nearby non-cancerous tissues, respectively. The frequency of aberrant promoter methylation of cancerous tissues was significant higher than non-cancerous tissues in p16, SOCS-1, and APC genes (p

KW - Direct sequencing

KW - Immunohistochemistry

KW - Methylation specific PCR

KW - Multiple methylation phenotype

KW - Tumor suppressor genes

UR - http://www.scopus.com/inward/record.url?scp=3242749984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242749984&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 341

EP - 348

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 2

ER -